Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · IEX Real-Time Price · USD

0.440

-0.031 (-6.56%)

At close: Jul 19, 2024, 4:00 PM

0.408

-0.032 (-7.25%)

Pre-market: Jul 22, 2024, 7:32 AM EDT

Aptevo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Revenue	0	0	3.11	12.29	4.31	0	Upgrade
Revenue Growth (YoY)	-	-	-74.67%	185.26%	-	-	Upgrade
Gross Profit	0	0	3.11	12.29	4.31	0	Upgrade
Selling, General & Admin	11.41	11.77	13.87	14.7	13.95	16.2	Upgrade
Research & Development	16.69	17.11	17.88	18.99	17.85	24.76	Upgrade
Other Operating Expenses	0	0	0	0	1.33	0	Upgrade
Operating Expenses	28.11	28.88	31.76	33.69	33.13	40.96	Upgrade
Operating Income	-28.11	-28.88	-28.64	-21.4	-28.82	-40.96	Upgrade
Other Expense / Income	-1.09	-11.47	-36.67	7.06	-11.07	-0.51	Upgrade
Pretax Income	-27.02	-17.41	8.03	-28.46	-17.75	-40.45	Upgrade
Net Income	-27.02	-17.41	8.03	-28.46	-17.75	-40.45	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	0	Upgrade
Shares Change	330.29%	139.76%	8.85%	38.25%	16.25%	81.50%	Upgrade
EPS (Basic)	-92.23	-62.48	69.08	-267.08	-230.12	-609.84	Upgrade
EPS (Diluted)	-92.23	-62.48	69.08	-267.08	-230.12	-609.84	Upgrade
Free Cash Flow	-22.95	-11.73	-21.05	-22.39	-29.41	-42.54	Upgrade
Free Cash Flow Per Share	-33.41	-42.19	-181.60	-210.17	-381.57	-641.61	Upgrade
Gross Margin	-	-	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-	-	-919.75%	-174.10%	-668.81%	-	Upgrade
Profit Margin	-	-	257.77%	-231.51%	-411.93%	-	Upgrade
Free Cash Flow Margin	-	-	-676.01%	-182.17%	-682.43%	-	Upgrade
EBITDA	-26.52	-16.84	8.93	-27.31	-16.34	-38.21	Upgrade
EBITDA Margin	-	-	286.71%	-222.20%	-379.30%	-	Upgrade
Depreciation & Amortization	0.5	0.57	0.9	1.14	1.41	2.24	Upgrade
EBIT	-27.02	-17.41	8.03	-28.46	-17.75	-40.45	Upgrade
EBIT Margin	-	-	257.77%	-231.51%	-411.93%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).